SYNFLORIX

This brand name is authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug SYNFLORIX contains a combination of these active pharmaceutical ingredients (APIs):

1	Pneumococcal polysaccharide serotype 1 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
2	Pneumococcal polysaccharide serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
3	Pneumococcal polysaccharide serotype 5 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
4	Pneumococcal polysaccharide serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
5	Pneumococcal polysaccharide serotype 7F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
6	Pneumococcal polysaccharide serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
7	Pneumococcal polysaccharide serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
8	Pneumococcal polysaccharide serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
9	Pneumococcal polysaccharide serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
10	Pneumococcal polysaccharide serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07AL52	Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510611401151316
CA	Health Products and Food Branch	02320541
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	60-MBE-0716
EE	Ravimiamet	1413098, 1413100, 1413111, 1413122, 1414404, 1414415, 1516069, 1754209, 1754210
ES	Centro de información online de medicamentos de la AEMPS	09508003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	142674, 142685
FR	Base de données publique des médicaments	68957822
IT	Agenzia del Farmaco	039104017, 039104029, 039104031, 039104043, 039104056, 039104068, 039104070, 039104082, 039104094, 039104106, 039104118, 039104120
LT	Valstybinė vaistų kontrolės tarnyba	1037115, 1037116, 1037117, 1037118, 1037119, 1061194, 1084499, 1084500, 1084501, 1084502, 1084503, 1084504
NG	Registered Drug Product Database	A6-0492
Switch country to Nigeria in order to find specific presentations of SYNFLORIX
NL	Z-Index G-Standaard, PRK	98558
NZ	Medicines and Medical Devices Safety Authority	13935
PL	Rejestru Produktów Leczniczych	100203585
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W54158001, W54158002, W54158003, W54158004, W54158005, W54159001, W54159002, W54159003, W54159004
SG	Health Sciences Authority	13775P
TN	Direction de la Pharmacie et du Médicament	7063141
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522967155, 8699522969609
ZA	Health Products Regulatory Authority	43/30.2/0401